Company Data

Corvus Pharmaceuticals Inc.

Ticker
CRVS
Current Price
$4.19 -4.99%
Market Cap
$269.2M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$1.3 - $10
Advanced Market Data

Overview

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy